Alembic Pharma (ALPM) exhibited in-line revenue with a slight miss on EBITDA/PAT for the quarter. While ex-US export growth was strong for the quarter, it was offset by moderate YoY growth in domestic ...

Alembic Pharmaceuticals reported a steady operating performance in Q3, with revenue rising 10.8% year-on-year to ₹1,876.3 crore, supported by consistent execution across domestic and international ...

Abstract: Bayesian inference provides a methodology for parameter estimation and uncertainty quantification in machine learning and deep learning methods. Variational inference and Markov Chain ...

Alembic Pharmaceuticals receives USFDA approval for generic Difluprednate ophthalmic emulsion to treat eye inflammation and pain after surgery. New Delhi, Jan 27 (PTI) Alembic Pharmaceuticals Ltd on ...

Alembic Technologies, a pioneer in Causal AI for the enterprise, today announced it has secured $145 million in Series B and growth funding - a 15.7x increase in valuation over their Series A round.

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Ready to develop your first AWS Lambda function in Python? It really couldn’t be easier. The AWS ...

Thinking about learning Python? It’s a pretty popular language these days, and for good reason. It’s not super complicated, which is nice if you’re just starting out. We’ve put together a guide that ...